Compare EVO & TWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | TWO |
|---|---|---|
| Founded | 1993 | 2009 |
| Country | Germany | United States |
| Employees | 4553 | 486 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | N/A | N/A |
| Metric | EVO | TWO |
|---|---|---|
| Price | $3.07 | $12.35 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 7 |
| Target Price | $7.00 | ★ $12.56 |
| AVG Volume (30 Days) | 47.1K | ★ 2.3M |
| Earning Date | 04-08-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 11.77% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.37 | N/A |
| Revenue Next Year | $10.05 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.31 | $8.84 |
| 52 Week High | $4.42 | $14.17 |
| Indicator | EVO | TWO |
|---|---|---|
| Relative Strength Index (RSI) | 56.03 | 57.92 |
| Support Level | $2.88 | $9.53 |
| Resistance Level | $3.75 | $12.70 |
| Average True Range (ATR) | 0.07 | 0.12 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 89.58 | 14.61 |
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, residential mortgage loans, mortgage servicing rights, and commercial real estate. The majority of its investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. The company derives revenues mainly from its MSR and Agency RMBS portfolio, including servicing fee income, float income, and interest income, as well as mortgage loan origination activities established to support the MSR portfolio. Its investment portfolio is subject to market risks, mainly interest rate, basis, and prepayment risk. The majority of income is generated by available-for-sale securities.